Thalocan Research Innovations and AGAPE Strategic Solutions of Maryland, LLC align on the significance of including patient perspectives and the social determinant of health in clinical research that includes the input of all relevant populations. Building trust in the engagement process and utilizing patient-centered tools to capture the accuracy of clinician and patient-reported outcomes help…
August is observed as hair loss awareness month, and we here at Thalocan Research Innovations are proud to join organizations like the National Alopecia Areata Foundation in raising awareness and drawing attention to this significant challenge that can impact a person’s health, confidence and overall well-being. Recently, we partnered with Arash Mostaghimi, MD, MPA, MPH…
Old school paper record keeping is time-consuming with a higher potential for missteps. Avoiding this is just ONE of the many reasons we designed LAMA. A patent-pending, BYOD cloud-based solution, Thalocan’s Lesion Area Mapping Assistant (LAMA) is built on a single concept: improve lesion assessment during dermatologic clinical trials with a streamlined, comprehensive and structured…
Meet Portia Combow, who has battled Hidradenitis Suppurativa (HS) for nearly two decades. Portia has been generous enough to share her experiences around the stigma, her long journey to diagnosis, as well as her own discovery of disease management strategies. At Thalocan we work to improve the process of disease assessment in clinical research, the patient experience informs all…
